Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 21 Mar 22 424B3 Prospectus supplement
- 17 Mar 22 EFFECT Notice of effectiveness
- 10 Mar 22 POS AM Prospectus update (post-effective amendment)
- 18 Oct 21 424B3 Prospectus supplement
- 25 Jun 21 424B3 Prospectus supplement
- 25 Jun 21 EFFECT Notice of effectiveness
-
15 Jun 21 F-1 Registration statement (foreign)
BCTX similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the reference to our firm under the caption “Experts and Legal Matters” and to the use of our report dated November 30, 2020 relating to the consolidated financial statements of BriaCell Therapeutics Corp. in the Registration Statement (Form F-1) and the related Prospectus of BriaCell Therapeutics Corp. dated June 14, 2021.
June 14, 2021 | /s/ MNP LLP |
Chartered Professional Accountants | |
Mississauga, Canada | Licensed Public Accountants |